@xconomy.com 27 days ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com 5 months ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com 11 months ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com 1 year ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com 2 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M